Local Anti-miR Delivery: The Latest in the Arsenal of Drug-Eluting Stents.
作者信息
Moore Kathryn J, Rayner Katey J
机构信息
From the Marc and Ruti Bell Vascular Biology and Disease Program, Leon H. Charney Division of Cardiology, Department of Medicine, New York University School of Medicine, New York (K.J.M.); and Department of Biochemistry, Microbiology & Immunology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada (K.J.R.).
出版信息
Arterioscler Thromb Vasc Biol. 2015 Sep;35(9):1905-6. doi: 10.1161/ATVBAHA.115.306187.
Abstract
摘要
相似文献
1
Local Anti-miR Delivery: The Latest in the Arsenal of Drug-Eluting Stents.
Arterioscler Thromb Vasc Biol. 2015 Sep;35(9):1905-6. doi: 10.1161/ATVBAHA.115.306187.
2
Local MicroRNA Modulation Using a Novel Anti-miR-21-Eluting Stent Effectively Prevents Experimental In-Stent Restenosis.
Arterioscler Thromb Vasc Biol. 2015 Sep;35(9):1945-53. doi: 10.1161/ATVBAHA.115.305597. Epub 2015 Jul 16.
3
Particle debris from a nanoporous stent coating obscures potential antiproliferative effects of tacrolimus-eluting stents in a porcine model of restenosis.
Catheter Cardiovasc Interv. 2005 Jan;64(1):85-90. doi: 10.1002/ccd.20213.
4
Drug-eluting stents.
Minerva Cardioangiol. 2002 Oct;50(5):419-29.
5
[Drug-eluting stents do they make the difference? ].
Minerva Cardioangiol. 2002 Oct;50(5):431-42.
6
Some aspects of drug eluting stents.
Int J Cardiol. 2007 Jul 31;119(3):380-3. doi: 10.1016/j.ijcard.2006.07.175. Epub 2006 Oct 24.
7
Dual drug release from stents-will we be happy with thing one and thing two?
Catheter Cardiovasc Interv. 2007 Nov 15;70(6):880. doi: 10.1002/ccd.21420.
8
[Drug-eluting coronary stents and drug eluting balloon catheters: summary of the position papers of the DGK].
Clin Res Cardiol. 2008 Aug;97(8):548-63. doi: 10.1007/s00392-008-0703-4.
9
[Position paper on the use of drug eluting stents in coronary heart disease].
Z Kardiol. 2004 May;93(5):416-22. doi: 10.1007/s00392-004-0119-8.
10
Could Paclitaxel-eluting stents be superior to sirolimus-eluting stents for the treatment of saphenous vein graft lesions?
Am J Cardiol. 2010 Nov 1;106(9):1367-8. doi: 10.1016/j.amjcard.2010.08.008.
引用本文的文献
1
Drug-Eluting Stent Targeting Sp-1-Attenuated Restenosis by Engaging YAP-Mediated Vascular Smooth Muscle Cell Phenotypic Modulation.
J Am Heart Assoc. 2020 Jan 7;9(1):e014103. doi: 10.1161/JAHA.119.014103. Epub 2019 Dec 27.
2
A Regulator of Metabolic Reprogramming: MicroRNA Let-7.
Transl Oncol. 2019 Jul;12(7):1005-1013. doi: 10.1016/j.tranon.2019.04.013. Epub 2019 May 22.
本文引用的文献
1
Local MicroRNA Modulation Using a Novel Anti-miR-21-Eluting Stent Effectively Prevents Experimental In-Stent Restenosis.
Arterioscler Thromb Vasc Biol. 2015 Sep;35(9):1945-53. doi: 10.1161/ATVBAHA.115.305597. Epub 2015 Jul 16.
2
Reducing In-Stent Restenosis: Therapeutic Manipulation of miRNA in Vascular Remodeling and Inflammation.
J Am Coll Cardiol. 2015 Jun 2;65(21):2314-27. doi: 10.1016/j.jacc.2015.03.549.
3
MicroRNAs in cardiovascular disease: an introduction for clinicians.
Heart. 2015 Jun;101(12):921-8. doi: 10.1136/heartjnl-2013-305402. Epub 2015 Mar 26.
4
Current treatment of in-stent restenosis.
J Am Coll Cardiol. 2014 Jun 24;63(24):2659-73. doi: 10.1016/j.jacc.2014.02.545. Epub 2014 Mar 13.
5
miRNA-21 is dysregulated in response to vein grafting in multiple models and genetic ablation in mice attenuates neointima formation.
Eur Heart J. 2013 Jun;34(22):1636-43. doi: 10.1093/eurheartj/eht105. Epub 2013 Mar 25.
6
Pathologic Etiologies of Late and Very Late Stent Thrombosis following First-Generation Drug-Eluting Stent Placement.
Thrombosis. 2012;2012:608593. doi: 10.1155/2012/608593. Epub 2012 Nov 21.
7
The importance of the endothelium in atherothrombosis and coronary stenting.
Nat Rev Cardiol. 2012 May 22;9(8):439-53. doi: 10.1038/nrcardio.2012.64.
8
MicroRNA-21 blocks abdominal aortic aneurysm development and nicotine-augmented expansion.
Sci Transl Med. 2012 Feb 22;4(122):122ra22. doi: 10.1126/scitranslmed.3003441.
9
MicroRNA-21 regulates vascular smooth muscle cell function via targeting tropomyosin 1 in arteriosclerosis obliterans of lower extremities.
Arterioscler Thromb Vasc Biol. 2011 Sep;31(9):2044-53. doi: 10.1161/ATVBAHA.111.229559. Epub 2011 Aug 4.
10
Treatment of drug-eluting stent restenosis the new pilgrimage: quo vadis?
J Am Coll Cardiol. 2010 Jun 15;55(24):2717-20. doi: 10.1016/j.jacc.2010.03.026.
Zotero 插件